| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEODERIV | Sep 1 | D | 228,000 | $41.21 | $9.4M? |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEODERIV | Sep 1 | D | 313,000 | $48.14 | $15.1M? |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEODERIV | Sep 1 | D | 240,000 | $41.49 | $10.0M? |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEODERIV | Sep 1 | D | 287,700 | $65.36 | $18.8M? |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEODERIV | Sep 1 | D | 244,205 | $64.98 | $15.9M? |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEODERIV | Sep 1 | D | 259,058 | $69.71 | $18.1M? |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEODERIV | Sep 1 | D | 195,578 | $62.39 | $12.2M? |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEODERIV | Sep 1 | D | 172,281 | $59.81 | $10.3M? |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Sep 1 | D | 176,663 | $85.00 | $15.0M |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Sep 1 | D | 80,000 | $85.00 | $6.8M |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Sep 1 | D | 111,100 | $85.00 | $9.4M |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Sep 1 | D | 111,100 | $85.00 | $9.4M |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Sep 1 | D | 111,100 | $85.00 | $9.4M |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Sep 1 | D | 111,100 | $85.00 | $9.4M |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Sep 1 | D | 100,000 | $85.00 | $8.5M |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Sep 1 | D | 110,000 | $85.00 | $9.3M |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Sep 1 | D | 106,000 | $85.00 | $9.0M |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Sep 1 | D | 136,805 | $85.00 | $11.6M |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Sep 1 | D | 1,000 | $85.00 | $85K |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Sep 1 | D | 248,043 | $85.00 | $21.1M |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEODERIV | Aug 7 | M | 4,995 | $0.00 | —? |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEODERIV | Aug 7 | M | 6,542 | $0.00 | —? |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEODERIV | Aug 7 | M | 4,422 | $0.00 | —? |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEODERIV | Aug 7 | M | 3,969 | $0.00 | —? |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Aug 7 | M | 4,995 | $20.02 | $100K |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Aug 7 | M | 6,542 | $15.29 | $100K |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Aug 7 | M | 4,422 | $22.61 | $100K |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Aug 7 | M | 3,969 | $25.19 | $100K |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | May 29 | G | 111,100 | $0.00 | — |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | May 29 | G | 111,100 | $0.00 | — |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | May 29 | G | 111,100 | $0.00 | — |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | May 29 | G | 111,100 | $0.00 | — |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | May 29 | G | 111,100 | $0.00 | — |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | May 29 | G | 111,100 | $0.00 | — |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | May 29 | G | 111,100 | $0.00 | — |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | May 29 | G | 111,100 | $0.00 | — |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | May 29 | G | 80,000 | $0.00 | — |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | May 29 | G | 222,200 | $0.00 | — |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | May 29 | G | 222,200 | $0.00 | — |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | May 29 | G | 80,000 | $0.00 | — |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | May 29 | G | 222,200 | $0.00 | — |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | May 29 | G | 222,200 | $0.00 | — |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Mar 16 | SPLAN | 8,785 | $37.77 | $332K |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Mar 16 | SPLAN | 13,196 | $37.11 | $490K |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEODERIV | Feb 23 | A | 228,000 | $0.00 | —? |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Feb 23 | A | 62,000 | $0.00 | — |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEODERIV | Dec 18 | M | 28,400 | $0.00 | —? |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEODERIV | Dec 18 | M | 16,342 | $0.00 | —? |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Dec 18 | M | 28,400 | $15.29 | $434K |
| Crinetics Pharmaceuticals, Inc. | CRNX | Richard Scott StruthersCEO | Dec 18 | M | 16,342 | $9.28 | $152K |